Isotonic Design for Phase I Clinical Trials: Can We Improve Further?

Austrian Journal of Statistics - Austria
doi 10.17713/ajs.v48i5.883
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Austrian Statistical Society

Related search

A Dose-Schedule Finding Design for Phase I-Ii Clinical Trials

Journal of the Royal Statistical Society. Series C: Applied Statistics
UncertaintyStatisticsProbability
2015English

Phase I Cancer Clinical Trials

British Journal of Cancer
Cancer ResearchOncology
2007English

A Dynamic Stopping Rule for Phase I Clinical Trials

Biometrical Letters
2018English

Using Electronic Health Records for Clinical Trials: Where Do We Stand and Where Can We Go?

CMAJ
Medicine
2019English

Sequential Designs for Phase I Clinical Trials With Late-Onset Toxicities

Biometrics
StatisticsGeneticsProbabilityMolecular BiologyBiochemistryApplied MathematicsMicrobiology ImmunologyBiological SciencesMedicineAgricultural
2000English

Peer Review for Biomedical Publications: We Can Improve the System

BMC Medicine
Medicine
2014English

International Disaster Relief—How Can We Improve?

Prehospital and Disaster Medicine
Emergency NursingEmergency Medicine
2002English

Escalation With Overdose Control Using Time to Toxicity for Cancer Phase I Clinical Trials

PLoS ONE
Multidisciplinary
2014English

Innovative Study Design for Paediatric Clinical Trials

European Journal of Clinical Pharmacology
MedicinePharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy